Page last updated: 2024-09-05

bms204352 and glyburide

bms204352 has been researched along with glyburide in 4 studies

Compound Research Comparison

Studies
(bms204352)
Trials
(bms204352)
Recent Studies (post-2010)
(bms204352)
Studies
(glyburide)
Trials
(glyburide)
Recent Studies (post-2010) (glyburide)
491126,5546201,344

Protein Interaction Comparison

ProteinTaxonomybms204352 (IC50)glyburide (IC50)
ATP-binding cassette sub-family C member 9Homo sapiens (human)0.22
Bile salt export pumpRattus norvegicus (Norway rat)5.7
Bile salt export pumpHomo sapiens (human)5.5333
Cytochrome P450 2C9 Homo sapiens (human)1.602
ATP-binding cassette sub-family C member 8Homo sapiens (human)0.0043
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)0.1121
NACHT, LRR and PYD domains-containing protein 3 Mus musculus (house mouse)10
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.8

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, WA; Coghlan, MJ; Gopalakrishnan, M1
Lombardo, F; Obach, RS; Waters, NJ1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Reviews

1 review(s) available for bms204352 and glyburide

ArticleYear
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
    Journal of medicinal chemistry, 2001, May-24, Volume: 44, Issue:11

    Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence

2001

Other Studies

3 other study(ies) available for bms204352 and glyburide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013